These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35848881)

  • 21. Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity.
    Peters PN; Schryver EM; Lengyel E; Kenny H
    J Vis Exp; 2015 Dec; (106):e53541. PubMed ID: 26780294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatocyte growth factor secreted by ovarian cancer cells stimulates peritoneal implantation via the mesothelial-mesenchymal transition of the peritoneum.
    Nakamura M; Ono YJ; Kanemura M; Tanaka T; Hayashi M; Terai Y; Ohmichi M
    Gynecol Oncol; 2015 Nov; 139(2):345-54. PubMed ID: 26335595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Src family kinase activity is required for signal tranducer and activator of transcription 3 and focal adhesion kinase phosphorylation and vascular endothelial growth factor signaling in vivo and for anchorage-dependent and -independent growth of human tumor cells.
    Laird AD; Li G; Moss KG; Blake RA; Broome MA; Cherrington JM; Mendel DB
    Mol Cancer Ther; 2003 May; 2(5):461-9. PubMed ID: 12748308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression and function of beta 1 and alpha v beta 3 integrins in ovarian cancer.
    Cannistra SA; Ottensmeier C; Niloff J; Orta B; DiCarlo J
    Gynecol Oncol; 1995 Aug; 58(2):216-25. PubMed ID: 7542622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of p27(Kip1) in dasatinib-enhanced paclitaxel cytotoxicity in human ovarian cancer cells.
    Le XF; Mao W; He G; Claret FX; Xia W; Ahmed AA; Hung MC; Siddik ZH; Bast RC
    J Natl Cancer Inst; 2011 Sep; 103(18):1403-22. PubMed ID: 21813412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Upregulation of mesothelial genes in ovarian carcinoma cells is associated with an unfavorable clinical outcome and the promotion of cancer cell adhesion.
    Ojasalu K; Brehm C; Hartung K; Nischak M; Finkernagel F; Rexin P; Nist A; Pavlakis E; Stiewe T; Jansen JM; Wagner U; Gattenlöhner S; Bräuninger A; Müller-Brüsselbach S; Reinartz S; Müller R
    Mol Oncol; 2020 Sep; 14(9):2142-2162. PubMed ID: 32533757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SMYD3 promotes implant metastasis of ovarian cancer via H3K4 trimethylation of integrin promoters.
    Lyu T; Jiang Y; Jia N; Che X; Li Q; Yu Y; Hua K; Bast RC; Feng W
    Int J Cancer; 2020 Mar; 146(6):1553-1567. PubMed ID: 31503345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alternatively-Activated Macrophages Upregulate Mesothelial Expression of P-Selectin to Enhance Adhesion of Ovarian Cancer Cells.
    Carroll MJ; Fogg KC; Patel HA; Krause HB; Mancha AS; Patankar MS; Weisman PS; Barroilhet L; Kreeger PK
    Cancer Res; 2018 Jul; 78(13):3560-3573. PubMed ID: 29739756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of c-Src and phospho-Src in epithelial ovarian carcinoma.
    Huang YW; Chen C; Xu MM; Li JD; Xiao J; Zhu XF
    Mol Cell Biochem; 2013 Apr; 376(1-2):73-9. PubMed ID: 23277333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity.
    Hart PC; Bajwa P; Kenny HA
    Adv Exp Med Biol; 2021; 1330():75-94. PubMed ID: 34339031
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Synthetic Lethality Screen Using a Focused siRNA Library to Identify Sensitizers to Dasatinib Therapy for the Treatment of Epithelial Ovarian Cancer.
    Pathak HB; Zhou Y; Sethi G; Hirst J; Schilder RJ; Golemis EA; Godwin AK
    PLoS One; 2015; 10(12):e0144126. PubMed ID: 26637171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metastatic dissemination of human ovarian epithelial carcinoma is promoted by alpha2beta1-integrin-mediated interaction with type I collagen.
    Fishman DA; Kearns A; Chilukuri K; Bafetti LM; O'Toole EA; Georgacopoulos J; Ravosa MJ; Stack MS
    Invasion Metastasis; 1998; 18(1):15-26. PubMed ID: 10207247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lysophosphatidic acid is constitutively produced by human peritoneal mesothelial cells and enhances adhesion, migration, and invasion of ovarian cancer cells.
    Ren J; Xiao YJ; Singh LS; Zhao X; Zhao Z; Feng L; Rose TM; Prestwich GD; Xu Y
    Cancer Res; 2006 Mar; 66(6):3006-14. PubMed ID: 16540649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of the prometastatic neuregulin-MMP13 axis by SRC family kinases: therapeutic implications.
    Orive-Ramos A; Seoane S; Ocaña A; Pandiella A; Montero JC
    Mol Oncol; 2017 Dec; 11(12):1788-1805. PubMed ID: 29032615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of Src family kinases overcomes anoikis resistance induced by spheroid formation and facilitates cisplatin-induced apoptosis in human mesothelioma cells.
    Eguchi R; Fujita Y; Tabata C; Ogawa H; Wakabayashi I; Nakano T; Fujimori Y
    Oncol Rep; 2015 Nov; 34(5):2305-10. PubMed ID: 26323315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microenvironmental regulation of membrane type 1 matrix metalloproteinase activity in ovarian carcinoma cells via collagen-induced EGR1 expression.
    Barbolina MV; Adley BP; Ariztia EV; Liu Y; Stack MS
    J Biol Chem; 2007 Feb; 282(7):4924-4931. PubMed ID: 17158885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-92a inhibits peritoneal dissemination of ovarian cancer cells by inhibiting integrin α5 expression.
    Ohyagi-Hara C; Sawada K; Kamiura S; Tomita Y; Isobe A; Hashimoto K; Kinose Y; Mabuchi S; Hisamatsu T; Takahashi T; Kumasawa K; Nagata S; Morishige K; Lengyel E; Kurachi H; Kimura T
    Am J Pathol; 2013 May; 182(5):1876-89. PubMed ID: 23499550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Invasion of interstitial matrix by a novel cell line from primary peritoneal carcinosarcoma, and by established ovarian carcinoma cell lines: role of cell-matrix adhesion molecules, proteinases, and E-cadherin expression.
    Kokenyesi R; Murray KP; Benshushan A; Huntley ED; Kao MS
    Gynecol Oncol; 2003 Apr; 89(1):60-72. PubMed ID: 12694655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. c-Met overexpression is a prognostic factor in ovarian cancer and an effective target for inhibition of peritoneal dissemination and invasion.
    Sawada K; Radjabi AR; Shinomiya N; Kistner E; Kenny H; Becker AR; Turkyilmaz MA; Salgia R; Yamada SD; Vande Woude GF; Tretiakova MS; Lengyel E
    Cancer Res; 2007 Feb; 67(4):1670-9. PubMed ID: 17308108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endostatin binding to ovarian cancer cells inhibits peritoneal attachment and dissemination.
    Yokoyama Y; Sedgewick G; Ramakrishnan S
    Cancer Res; 2007 Nov; 67(22):10813-22. PubMed ID: 18006826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.